Stephen J. Tulipano
2017 - Aldeyra Therapeutics
In 2017, Stephen J. Tulipano earned a total compensation of $1.3M as Chief Financial Officer at Aldeyra Therapeutics, a 152% increase compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $114,984 |
|---|---|
| Option Awards | $844,702 |
| Salary | $324,005 |
| Total | $1,283,691 |
Tulipano received $844.7K in option awards, accounting for 66% of the total pay in 2017.
Tulipano also received $115K in non-equity incentive plan and $324K in salary.
Rankings
In 2017, Stephen J. Tulipano's compensation ranked 7,780th out of 14,666 executives tracked by ExecPay. In other words, Tulipano earned more than 47.0% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 7,780 out of 14,666 | 47th |
Division Manufacturing | 2,912 out of 5,768 | 50th |
Major group Chemicals And Allied Products | 946 out of 2,074 | 54th |
Industry group Drugs | 733 out of 1,730 | 58th |
Industry Pharmaceutical Preparations | 572 out of 1,329 | 57th |
Source: SEC filing on April 25, 2018.
Tulipano's colleagues
We found two more compensation records of executives who worked with Stephen J. Tulipano at Aldeyra Therapeutics in 2017.